Johnson & Johnson (JNJ) Wins EU Approval For TECVAYLI Combo In Multiple Myeloma
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Johnson & Johnson Stock Jumps 3% as Healthcare Rotation Lifts Shares
This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ), the healthcare heavyweight behind blockbuster medicines and medical…
We’re lifting our price target on Cardinal Health after issuing rosy profit guidance
Cardinal Health on Tuesday showed why the healthcare distributor belongs in our portfolio, delivering robust full-year earnings guidance…
AstraZeneca stock falls as investors balk at reported Bristol Myers tie-up
AstraZeneca shares dropped as much as 7% on Monday after reports that the company had discussed a potential…
How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k)
Quick Read Generating $108,000 annually from dividends requires roughly $2.7M at a 4% yield, $1.8M at 6%, or…
Market for psychedelic drugs to treat mental health gets a buy signal
Psilocybin mushrooms stand ready for harvest in a humidified “fruiting chamber.” John Moore | Getty Images Thursday’s announcement…
We’re trimming a stock into strength, raising our price target
We are selling 50 shares of Cardinal Health at roughly $235. Following the trade, Jim Cramer’s Charitable Trust…
Johnson & Johnson CEO: America’s innovation advantage starts with healthÂ
Johnson & Johnson CEO: America’s innovation advantage starts with health | Fortune Joaquin Duato is Chairman and Chief…
How The Narrative On Johnson & Johnson (JNJ) Is Shifting With New Targets And Litigation Risks
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Johnson & Johnson Vs. Pfizer
As large tech companies struggled this year, investors have had a chance to reevaluate their portfolios and identify…